Company news

Sernova Biotherapeutics Inc news in 2024

Sernova Biotherapeutics Inc's news releases, calls and decks from 2024, newest first.

View company

Sernova Announces Key New Executive Appointments

October 11, 2024

Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa

October 3, 2024

Sernova Appoints David Paterson Ph.D. to its Board of Directors

September 19, 2024

Sernova to Participate in Upcoming H.C. Wainwright Investor Conference

September 5, 2024

Sernova Closes $5.2 Million Over-Subscribed Non-Brokered, Private Placement

September 4, 2024

Sernova Announces Oversubscribed Non-Brokered Private Placement

August 29, 2024

Sernova Announces Up to $4 Million Private Placement Priced at a Premium

August 20, 2024

Lead Investigator for Sernova's Clinical Trial with Cell Pouch for Type 1 Diabetes to Deliver Oral Presentation at the 2024 EASD Annual Meeting

August 15, 2024

Jonathan Rigby Appointed as Executive Chairman for Sernova

July 15, 2024

Sernova Announces Additional Patient Insulin Independent and Cohort 2 Enrollment Complete in Ongoing Phase I/II Clinical Trial for Treatment of Type 1 Diabetes

June 25, 2024

Sernova Provides Update on Public Offering

June 12, 2024

Sernova Announces Marketed Public Offering of Units

June 6, 2024

Sernova Appoints Jonathan Rigby to its Board of Directors

May 28, 2024

Sernova Announces AGM Voting Results

May 1, 2024

Sernova Provides Organizational Update

April 25, 2024

Sernova Welcomes Dr. Bernd Muehlenweg as Evotec's Nominee for its Board of Directors

April 22, 2024

Sernova Provides Positive Clinical and Platform Portfolio Update

April 2, 2024

Sernova Announces Management Developments

March 11, 2024

Sernova Provides Recap of 2023 Accomplishments and Anticipated 2024 Milestones

January 29, 2024

Decks in 2024